Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- lepirudin
- revakinagene taroretcel
Interactions between your drugs
lepirudin revakinagene taroretcel ophthalmic
Applies to: lepirudin, revakinagene taroretcel
ADJUST DOSING INTERVAL: Coadministration of revakinagene taroretcel ophthalmic with drugs that can affect hemostasis such as anticoagulants, platelet inhibitors, thrombin inhibitors, thrombolytic agents, dextrans, and nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of vitreous hemorrhage, which may result in temporary vision loss.
MANAGEMENT: The manufacturer of revakinagene taroretcel ophthalmic recommends temporarily interrupting antithrombotic medications before revakinagene taroretcel implantation. Patients should be advised to promptly report any signs of blurred vision, vision loss, floaters, or flashes of light. Clinicians should consult relevant literature, local and national treatment guidelines, and package labeling for further guidance.
References (1)
- (2025) "Product Information. Encelto (revakinagene taroretcel ophthalmic)." Neurotech Pharmaceuticals, Inc
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Angiomax
Angiomax is used for angina, percutaneous coronary intervention
Pradaxa
Pradaxa (dabigatran) is used to prevent stroke and blood clots in patients with atrial ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Dabigatran
Dabigatran systemic is used for deep vein thrombosis, deep vein thrombosis, prophylaxis, deep vein ...
Bivalirudin
Bivalirudin systemic is used for angina, percutaneous coronary intervention
Argatroban
Argatroban systemic is used for thrombotic/thromboembolic disorder
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.